Related Experiment Video
Updated: Jul 19, 2025

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
Published on: July 19, 2007
Abstract:
The FDA is ramping up Project FrontRunner, which urges drugmakers to seek accelerated approval of experimental drugs as first-line treatments for patients with advanced or metastatic disease, rather than focusing on patients who have tried multiple therapies and/or exhausted available options. Experts say the program has the potential to expand access while improving the risk-benefit assessment of new drugs by initiating randomized controlled trials earlier in the drug development process.
Insights
The Food and Drug Administration
Area of Science:
- Oncology
- Drug Development
- Regulatory Science
Background:
- The U.S. Food and Drug Administration (FDA) is promoting Project FrontRunner.
- This initiative encourages pharmaceutical companies to pursue accelerated approval for novel therapeutics.
- Focus is on early-stage treatment for advanced or metastatic cancers.
Related Concept Videos
Clinical Trials: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug Regulation
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Drug Therapy
Antianxiety Medications

